Automated Modular Analyzer Provides Fast, Comprehensive Cell Culture Analysis
A new, automated modular analyzer from Nova Biomedical provides fast, comprehensive analysis for cell culture processing. BioProfileŽ FLEX provides up to 15 key cell culture attributes, including glucose, lactate, glutamine, glutamate, ammonium, PCO2, PO2, pH, sodium, potassium, calcium, osmolality, cell density/viability, and phosphate in a single, easy to use workstation.
Read more…
Nova StatStrip Glucose Analyzer Receives FDA Clearance for Neonatal Testing
Nova's new StatStrip™ Glucose Monitor has received clearance from the U.S. Food and Drug Administration for use in neonatal testing.
Read more…
First True "No Coding" Blood Glucose Monitoring System Provides Fast, Convenient Solution for Diabetes Self-Testing
An advanced blood glucose monitoring system from Nova Biomedical provides a fast, convenient solution for diabetes self-testing. The newly released Nova Max™ system is built around patented* new technology test strips that are so precise they do not require the calibration or coding required of currently available blood glucose monitors to perform a glucose test.
Read more…
"All-in-One" Stat Analyzer Adds Total Bilirubin to Test Menu
Nova Biomedical announces the incorporation of total bilirubin (tBil) to the comprehensive test menu on its Stat ProfileŽ Critical Care Xpress (CCX) "All-in-One" Analyzers.
Read more…
Point-of-Care Blood Glucose Monitoring System Measures and Correct Hematocrit and Electrochemical Interferences
An advanced blood glucose monitoring system from Nova Biomedical elevates bedside glucose testing to a new level of analytical performance that approaches the quality of central laboratory testing.
Read more…
Novation Contract Awarded to Nova Biomedical
Nova Biomedical is pleased to announce that it has been awarded a three-year agreement to provide its multi-analyte point of care testing instrumentation to Novation, effective August 1, 2005.
Read more…
Premier Contract Awarded to Nova Biomedical
Nova Biomedical is pleased to announce that it has been awarded a three-year contract to provide point of care/blood gas instrumentation to Premier, Inc., effective October 1, 2005.
Read more… |
